Debt-to-equity in % of CRESCENT BIOPHARMA, INC. from Q3 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CRESCENT BIOPHARMA, INC. quarterly Debt-to-equity history and change rate from Q3 2014 to Q3 2025.
  • CRESCENT BIOPHARMA, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 43%, a 76% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 43% +18% +76% 30 Sep 2025
Q2 2025 78% +61% +351% 30 Jun 2025
Q1 2025 -217% -233% -1516% 31 Mar 2025
Q4 2024 190% +176% +1302% 31 Dec 2024
Q3 2024 24% +10% +71% 30 Sep 2024
Q2 2024 17% +2.7% +18% 30 Jun 2024
Q1 2024 15% -0.35% -2.2% 31 Mar 2024
Q4 2023 14% -4.8% -26% 31 Dec 2023
Q3 2023 14% -2.9% -17% 30 Sep 2023
Q2 2023 15% -0.87% -5.6% 30 Jun 2023
Q1 2023 16% +1.8% +13% 31 Mar 2023
Q4 2022 18% +6.6% +56% 31 Dec 2022
Q3 2022 17% +6.1% +55% 30 Sep 2022
Q2 2022 16% +5.2% +51% 30 Jun 2022
Q1 2022 14% +4.1% +42% 31 Mar 2022
Q4 2021 12% +2.4% +25% 31 Dec 2021
Q3 2021 11% +2.1% +24% 30 Sep 2021
Q2 2021 10% +1.6% +18% 30 Jun 2021
Q1 2021 9.7% +1.3% +16% 31 Mar 2021
Q4 2020 9.4% +1.9% +25% 31 Dec 2020
Q3 2020 8.9% +2.4% +37% 30 Sep 2020
Q2 2020 8.7% +3.4% +65% 30 Jun 2020
Q1 2020 8.4% +4.2% +98% 31 Mar 2020
Q4 2019 7.6% +3.8% +101% 31 Dec 2019
Q3 2019 6.5% +2.4% +58% 30 Sep 2019
Q2 2019 5.3% +0.48% +10% 30 Jun 2019
Q1 2019 4.2% -1.2% -22% 31 Mar 2019
Q4 2018 3.8% -3.6% -49% 31 Dec 2018
Q3 2018 4.1% -4.8% -54% 30 Sep 2018
Q2 2018 4.8% -6.3% -57% 30 Jun 2018
Q1 2018 5.4% -11% -66% 31 Mar 2018
Q4 2017 7.4% -8.9% -55% 31 Dec 2017
Q3 2017 8.9% -7.5% -46% 30 Sep 2017
Q2 2017 11% -5% -31% 30 Jun 2017
Q1 2017 16% +0.67% +4.3% 31 Mar 2017
Q4 2016 16% +2.5% +18% 31 Dec 2016
Q3 2016 16% +4.1% +33% 30 Sep 2016
Q2 2016 16% +5.5% +52% 30 Jun 2016
Q1 2016 16% +6.8% +78% 31 Mar 2016
Q4 2015 14% +6% +79% 31 Dec 2015
Q3 2015 12% +4.8% +64% 30 Sep 2015
Q2 2015 11% 30 Jun 2015
Q1 2015 8.7% 31 Mar 2015
Q4 2014 7.7% 31 Dec 2014
Q3 2014 7.5% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.